Literature DB >> 9114781

Circulating interleukin-6 in severe heart failure.

G A MacGowan1, D L Mann, R L Kormos, A M Feldman, S Murali.   

Abstract

In a group of patients with New York Heart Association class IV heart failure, significant relations between interleukin-6 and tumor necrosis factor-alpha, and between levels of both interleukin-6 and tumor necrosis factor-alpha and plasma levels of norepinephrine were observed. The present study also demonstrates that in patients with heart failure, elevated levels of tumor necrosis factor-alpha and interleukin-6 may be present even without cachexia.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9114781     DOI： 10.1016/s0002-9149(96)00063-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  40 in total

Review 1.  The role of anti-cytokine therapy in the failing heart.

Authors:  A Deswal; A Misra; B Bozkurt
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

Review 2.  Cytokines and their receptors in cardiovascular diseases--role of gp130 signalling pathway in cardiac myocyte growth and maintenance.

Authors:  K Yamauchi-Takihara; T Kishimoto
Journal:  Int J Exp Pathol       Date:  2000-02       Impact factor: 1.925

Review 3.  Activation of cytokines as a mechanism of disease progression in heart failure.

Authors:  B Bozkurt
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 4.  Optimising outcomes in end-stage heart failure: differences in therapeutic responses between diverse ethnic groups.

Authors:  Shigetake Sasayama
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 5.  Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure.

Authors:  Holly R Middlekauff
Journal:  Circ Heart Fail       Date:  2010-07       Impact factor: 8.790

Review 6.  Reversal of maladaptive gene program in left ventricular myocardium of dogs with heart failure following long-term therapy with the Acorn Cardiac Support Device.

Authors:  Sharad Rastogi; Sudhish Mishra; Ramesh C Gupta; Hani N Sabbah
Journal:  Heart Fail Rev       Date:  2005-06       Impact factor: 4.214

Review 7.  New molecular insights into heart failure and cardiomyopathy: potential strategies and therapies.

Authors:  G A MacGowan; D M McNamara
Journal:  Ir J Med Sci       Date:  2002 Apr-Jun       Impact factor: 1.568

8.  Sympathoexcitation in response to cardiac and pulmonary afferent stimulation of TRPA1 channels is attenuated in rats with chronic heart failure.

Authors:  Ryan J Adam; Zhiqiu Xia; Kristina Pravoverov; Juan Hong; Adam J Case; Harold D Schultz; Steven J Lisco; Irving H Zucker; Han-Jun Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

9.  Heart failure causes cholinergic transdifferentiation of cardiac sympathetic nerves via gp130-signaling cytokines in rodents.

Authors:  Hideaki Kanazawa; Masaki Ieda; Kensuke Kimura; Takahide Arai; Haruko Kawaguchi-Manabe; Tomohiro Matsuhashi; Jin Endo; Motoaki Sano; Takashi Kawakami; Tokuhiro Kimura; Toshiaki Monkawa; Matsuhiko Hayashi; Akio Iwanami; Hideyuki Okano; Yasunori Okada; Hatsue Ishibashi-Ueda; Satoshi Ogawa; Keiichi Fukuda
Journal:  J Clin Invest       Date:  2010-01-04       Impact factor: 14.808

10.  Stimulation of adenosine A(2B) receptors induces interleukin-6 secretion in cardiac fibroblasts via the PKC-delta-P38 signalling pathway.

Authors:  Wei Feng; Yao Song; Chao Chen; Zhi Zhen Lu; Youyi Zhang
Journal:  Br J Pharmacol       Date:  2009-12-24       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.